U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class
Concept
Record UNII
Y5UN7AE8SF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
lanoracopan [INN]
Preferred Name English
Lanoracopan
INN  
Official Name English
Benzoic acid, 4-[(2S,4S)-4-(cyclopropylmethoxy)-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]-
Systematic Name English
4-[(2S,4S)-4-(Cyclopropylmethoxy)-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]benzoic acid
Systematic Name English
Code System Code Type Description
INN
13385
Created by admin on Wed Apr 02 18:45:07 GMT 2025 , Edited by admin on Wed Apr 02 18:45:07 GMT 2025
PRIMARY
CAS
2797066-85-2
Created by admin on Wed Apr 02 18:45:07 GMT 2025 , Edited by admin on Wed Apr 02 18:45:07 GMT 2025
PRIMARY
FDA UNII
Y5UN7AE8SF
Created by admin on Wed Apr 02 18:45:07 GMT 2025 , Edited by admin on Wed Apr 02 18:45:07 GMT 2025
PRIMARY
PUBCHEM
164517045
Created by admin on Wed Apr 02 18:45:07 GMT 2025 , Edited by admin on Wed Apr 02 18:45:07 GMT 2025
PRIMARY
This is a non-substance concept
Related Record Type Details
COMPLEMENT FACTOR B
TARGET -> INHIBITOR
Related Record Type Details
Lanoracopan
ACTIVE MOIETY
complement factor B inhibitor
This is a non-substance concept
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966